MedPath

Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation

Not Applicable
Conditions
Patients With at Least Single Missing Anterior Tooth
Thin Gingival Biotype
Interventions
Procedure: sub epithelial connective tissue graft
Procedure: Platelet Rich Fibrin
Registration Number
NCT03219944
Lead Sponsor
Cairo University
Brief Summary

Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
16
Inclusion Criteria
  1. Patients with missing maxillary anterior toot teeth.
  2. Thin gingival biotype.
  3. Adequate inter-arch space for placement of the implant prosthetic part.
  4. Good oral hygiene where gingival index is (0, 1) (Loe and Silness 1963).
Read More
Exclusion Criteria
  1. Patient with medical condition that is contraindicated with the surgical procedure
  2. Patients receiving treatment that affect the healing ability.
  3. Patients with local pathological defects related to the area of interest.
  4. Smokers or pregnant women.
  5. Patients with parafunctional habits that may jeopardize the implant longevity and affect the results of the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
sub epithelial connective tissue graftsub epithelial connective tissue graftThe connective tissue graft will be harvested from the palate. Then the SCTG will be placed over the recipient site extending palataly and sutured.
Platelet Rich Fibrin for soft tissue augmentationPlatelet Rich Fibrinblood will be drawn from the patient vein for PRF. The blood sample will be centrifuged for 10-12 min. PRF membrane is obtained
Primary Outcome Measures
NameTimeMethod
Crestal bone resorption6 months

measured mesially and distally using periapical xray in mm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maymohamedkamal

🇪🇬

Cairo, Elmaniel, Egypt

© Copyright 2025. All Rights Reserved by MedPath